Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
The Scandi Way AB
AB
Dissolved
Org 5593869612
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2022 · 4 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
The Scandi Way AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
Income statement
SEK thousands
Item
2022
Revenue
0
Staff expenses
—
EBITDA
−47
Depreciation & amort.
−0
EBIT
−47
Net financials
—
Profit before tax
−47
Tax
−0
Net profit
−47
Balance sheet
SEK thousands
Item
2022
Total assets
289
Equity
278
Long-term debt
0
Short-term debt
12
Total debt
12
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2022
2022
Equity ratio
96,2 %
This company
38,2 %
Market median
This company
Market median
152% above market
2022
2022
Return on equity
−16,9 %
This company
18,4 %
Market median
This company
Market median
192% below market
2022
2022
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2022
2022
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2022
2022
Debt / equity
0,04×
This company
0,62×
Market median
This company
Market median
94% below market
2022
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-06-01 – 2022-12-31
View
PDF
More on The Scandi Way AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
